Patients with metabolic disorders (obesity, T2DM) demonstrate increased breast cancer mortality in association with an altered expression profile of both RAGE and the IGF (insulin growth factor)-1/IGF-1R (receptor) axis (16, 60). The gene discussed is IGF1; the disease is obesity due to melanocortin 4 receptor deficiency.